Plain-English translation of NCT05666518 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world safety study of vericiguat, a medication that helps the heart pump blood more effectively by boosting a natural enzyme in your body. Researchers want to understand how safe this medication is for Japanese patients with chronic heart failure when used over a longer period, and whether it helps prevent serious heart-related events like heart attacks or strokes.
While this medication is already approved and available, doctors have only treated a limited number of patients with it so far. This study exists to fill important gaps about its safety in a broader and more diverse population—particularly Japanese patients—and to understand how well it works over extended treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will either start taking the new medication as part of your regular heart care, or continue with your current standard heart failure treatment. Either way, researchers will collect information about your health, any medical problems you experience, and how you are doing over time. This happens under real-world conditions—meaning at your regular doctor's visits—rather than in a controlled research setting.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Japan